Text this: Efficacy and safety of first-line necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin in East Asian patients with stage IV squamous non-small cell lung cancer: A subgroup analysis of the phase 3, open-label, randomized SQUIRE study

  _____    __   __    _  _     ______    _____   
 / ____||  \ \\/ //  | \| ||  /_   _//  /  ___|| 
/ //---`'   \ ` //   |  ' ||   -| ||-  | // __   
\ \\___      | ||    | .  ||   _| ||_  | \\_\ || 
 \_____||    |_||    |_|\_||  /_____//  \____//  
  `----`     `-`'    `-` -`   `-----`    `---`